Drug Development Technology Leader Arisglobal Completes Acquisition Of Amplexor Life Sciences
04/20/23, 12:04 PM
Location
walthamIndustry
software
science and engineering
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, today announces the completion of its acquisition of Amplexor Life Sciences. This deal will deliver the most intelligent, connected, and comprehensive regulatory platform available, bringing increased efficiency for life sciences organizations as they bring new therapies to market.
Company Info
Location
Waltham, Massachusetts, United States
Company info
ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans almost 40 years, LifeSphere® boosts efficiency, ensures compliance, and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture.